Laboratory

A laboratory measurement of high-density lipoprotein cholesterol in blood, expressed in mg/dL, where higher values are associated with reduced cardiovascular risk. HDL-C is included in standard lipid panel testing and contributes to total cardiovascular risk calculations. HDL-C below 40 mg/dL in men or 50 mg/dL in women is a component of metabolic syndrome criteria used in population health risk stratification programs.

A standardized calculation derived from prothrombin time that normalizes results across different laboratory reagents and instruments, enabling consistent monitoring of warfarin anticoagulation therapy. INR is the standard metric for warfarin dose adjustment, with therapeutic targets typically 2.0-3.0 for atrial fibrillation and venous thromboembolism prevention and 2.5-3.5 for mechanical heart valves. INR monitoring frequency is a component of HEDIS warfarin management measures.

The results of a laboratory panel assessing iron metabolism including serum iron, total iron binding capacity, transferrin saturation, and serum ferritin, used to diagnose iron deficiency anemia, anemia of chronic disease, and iron overload conditions such as hemochromatosis. Transferrin saturation below 20% with low ferritin indicates iron deficiency, while elevated ferritin with high transferrin saturation indicates iron overload.

A unique identifier for the laboratory information system instance that generated and reported a laboratory result, used in multi-facility health system data warehouses to identify the source system when integrating results from multiple hospitals and reference laboratories that may assign different accession numbers or test codes to equivalent tests. LIS identifier is essential for source-system-level data quality monitoring.

A code indicating the current status of a laboratory order in the processing workflow, with values such as ordered, collected, received, in process, resulted, and cancelled. Laboratory order status tracking is used in revenue cycle analytics to identify uncollected orders, in clinical operations to monitor turnaround times, and in quality analytics to track order-to-result completion rates for time-sensitive tests such as blood cultures and cardiac biomarkers.

A code indicating the urgency with which a laboratory order should be processed and resulted, with standard values including ROUTINE for standard priority processing, STAT for immediate processing of urgent clinical situations, ASAP for expedited processing, and TIMING-CRITICAL for tests requiring result within a specific time window relative to treatment such as drug levels. Laboratory priority codes drive specimen processing queues and turnaround time monitoring.

A flag identifying that a laboratory test was sent to an external reference laboratory for testing rather than being performed in-house, used in laboratory operations analytics to track reference laboratory utilization, costs, and turnaround times, and in revenue cycle analytics to ensure appropriate billing for send-out tests. Reference laboratory tests typically have longer turnaround times and higher costs than in-house testing.

A code classifying a laboratory test into a functional category such as chemistry, hematology, microbiology, immunology, molecular diagnostics, point-of-care, or anatomic pathology, used in laboratory information systems for test routing and data warehouse analytics segmenting result volumes, turnaround times, and quality metrics by laboratory discipline. Laboratory test category codes enable department-level performance benchmarking.

A unique identifier for a specific laboratory test or assay in a laboratory information system, used to link orders, results, reference ranges, and billing records to the correct test definition. Laboratory test codes are maintained in the test catalog and may map to LOINC codes for interoperability, CPT codes for billing, and internal analyzer codes for instrument routing in automated laboratory workflows.

A laboratory measurement of lactate concentration in blood, expressed in mmol/L, used as a biomarker of tissue hypoperfusion, cellular hypoxia, and metabolic stress in critically ill patients. Lactate above 2 mmol/L indicates hyperlactatemia and above 4 mmol/L is associated with septic shock and high mortality, guiding aggressive fluid resuscitation and vasopressor therapy in the Surviving Sepsis Campaign bundle.

A laboratory measurement of lipase enzyme activity in blood serum, expressed in U/L, used as the primary diagnostic test for acute pancreatitis when elevated above three times the upper limit of normal. Lipase is more specific for pancreatic injury than amylase and remains elevated longer after pancreatitis onset. Lipase levels are used in emergency department protocols for acute abdominal pain evaluation.

A laboratory measurement of low-density lipoprotein cholesterol in blood, expressed in mg/dL, used to assess cardiovascular risk and guide statin therapy decisions. LDL-C is a key component of lipid panel testing and is used in HEDIS Statin Use in Persons with Cardiovascular Disease measures, HCC risk adjustment documentation for hyperlipidemia, and population health analytics targeting members with elevated cardiovascular risk.

A binary flag indicating whether a microbiology laboratory record, such as a culture, sensitivity test, or organism identification, is currently active and valid for clinical use. Inactive records may reflect cancelled orders, superseded results, or tests removed from the active patient chart.

The current lifecycle state of a microbiology laboratory study, such as a bacterial culture or susceptibility panel. Status values may include active, cancelled, completed, or on hold, reflecting where the specimen and associated results stand within the laboratory workflow at any given time.

The street address associated with the facility, collection site, or patient record linked to a microbiology laboratory study. Used to identify where specimens were collected or where results should be reported, supporting care coordination and reference laboratory routing decisions.

The dollar amount applied to modify the original charge for a microbiology laboratory service, such as a culture or sensitivity test. Adjustments may reflect contractual write-offs, payer-negotiated discounts, or billing corrections applied during claims processing or revenue cycle reconciliation.

The age of the patient at the time a microbiology specimen was collected or a laboratory order was placed. Used in clinical reporting to correlate infection patterns, organism prevalence, and antimicrobial susceptibility trends across pediatric, adult, and geriatric patient populations.

The maximum dollar amount a payer will reimburse for a microbiology laboratory service under a specific health plan contract. Represents the contractually agreed rate for services such as bacterial cultures or pathogen identification, against which billed charges are compared during claims adjudication.

The total monetary value associated with a microbiology laboratory transaction, including charges for specimen processing, organism identification, and susceptibility testing. Used in revenue cycle management to track gross charges, payments, and financial performance of microbiology laboratory services.

The authorization state of a microbiology laboratory order or result, indicating whether the test has been reviewed, validated, or approved by a qualified clinical laboratorian or pathologist before being released to the ordering provider for clinical decision-making.